GenoSpectra appoints Whitney CEO

July 31, 2002 — GenoSpectra Inc., a Fremont, Calif. developer of drug discovery technologies using microfluidics and fiber optics, announced the appointment of Frank Whitney as chief executive officer, according to a news release. It is a newly created position.

Whitney was previously president of drug discovery tools at PerkinElmer Life Sciences. GenoSpectra was founded in April 2000.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.